These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 5381888)

  • 1. [Triple reserved scheme in the treatment of resistent forms of pulmonary tuberculosis (preliminary results)].
    Rizzo A; Magalhães M; Moura N
    Rev Bras Med; 1969 Sep; 26(9):504-10. PubMed ID: 5381888
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immediate results of treatment of tuberculosis patients with drugs of the second series].
    Ivanova ES; Komarova AA
    Sov Med; 1967 Jun; 30(6):107-10. PubMed ID: 5611339
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pulmonary tuberculosis resistant to streptomycin and isoniazid and treated wtih a combination of ethionamide, pyrazinamide, and cycloserine (200 cases)].
    Bartal M; Nejjar A; Laraki A
    Tunis Med; 1973 Jul; 51(4):237-43. PubMed ID: 4209977
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug therapy of resistant cases of pulmonary tuberculosis in Indian patients.
    Mital OP; Agarwala MC; Singh SK
    Indian J Chest Dis; 1967 Oct; 9(4):196-206. PubMed ID: 4323543
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of pulmonary tuberculosis with ethionamide, cycloserine and pyrazinamide in Hong Kong.
    Horsfall PA
    Bull Int Union Tuberc; 1972 Aug; 47 Suppl 2():91-100. PubMed ID: 4662516
    [No Abstract]   [Full Text] [Related]  

  • 6. Ethionamide, pyrazinamide and cycloserine in drug resistant cases.
    Narang RK; Singh SK
    Indian J Chest Dis; 1973 Jan; 15(1):16-20. PubMed ID: 4695462
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of treatment with a combined 3-drug regimen of secondary drugs in chronic cavernous pulmonary tuberculosis. A study under auspices of the International Union against Tuberculosis].
    Zierski M; Zacara A; Woźniak S
    Gruzlica; 1968 Sep; 36(9):809-18. PubMed ID: 4882450
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of pulmonary tuberculosis with reserve drugs in the light of our personal observations].
    Kochnowski G
    Wiad Lek; 1970 Jan; 23(1):9-13. PubMed ID: 4312765
    [No Abstract]   [Full Text] [Related]  

  • 9. [Triple drug regimen with reserve drugs: ETA, PZA and CS in the treatment of chronic pulmonary tuberculosis].
    Wagner J
    Gruzlica; 1966 Mar; 34(3):249-54. PubMed ID: 5947778
    [No Abstract]   [Full Text] [Related]  

  • 10. The treatment of drug resistant chronic pulmonary tuberculosis with new tuberculostatics.
    Zierski M
    Bull Int Union Tuberc; 1968 Dec; 41():194-200. PubMed ID: 4303863
    [No Abstract]   [Full Text] [Related]  

  • 11. [Autonomous treatment of pulmonary tuberculosis with delayed-action drugs].
    Pannain M; Tarantino AB; Mac Dowell A; Costa JA; Cunha JM; Pantoja W
    Rev Bras Med; 1967 Aug; 24(8):664-8. PubMed ID: 5603007
    [No Abstract]   [Full Text] [Related]  

  • 12. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
    Utkin VV; Rudoĭ NM
    Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical efficiency of cycloserine in association with other tuberculostatics.
    Anastasatu C; Ulpian C; Weiss P
    Scand J Respir Dis Suppl; 1970; 71():152-4. PubMed ID: 5271976
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of the therapeutic effects of secondary antitubercular agents].
    Watanabe S; Nosaki M; Iwasaki M; Hamano S; Furuya Y
    Iryo; 1966 Mar; 20(3):251-6. PubMed ID: 5965119
    [No Abstract]   [Full Text] [Related]  

  • 15. [Internal medicine treatment of pulmonary tuberculosis].
    Schaich W
    Med Klin; 1970 Sep; 65(36):1553-8. PubMed ID: 4995072
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of chronic polyresistant pulmonary tuberculosis using ethionamide, pyrazinamide and cycloserine].
    Sighart H; Opl G
    Prax Pneumol; 1968 Nov; 22(11):692-8. PubMed ID: 5714048
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experience in treatment of patients with chronic destructive pulmonary tuberculosis in a suburban tuberculosis hospital].
    Sirota DS; Man'kovetskiĭ EF; Koĭfman SG; Vatsyk MZ
    Probl Tuberk; 1974; (10):17-9. PubMed ID: 4370967
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preparations of the 2d series in the complex treatment of middle-aged and elderly patients with pulmonary tuberculosis].
    Iaschenko BP
    Probl Tuberk; 1967; 45(9):21-6. PubMed ID: 4303748
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical problems of resistance to secondary antitubercular agents].
    Baba H; Takahashi R; Nakai T; Torii R; Yo I
    Iryo; 1966 Mar; 20(3):230-40. PubMed ID: 5964830
    [No Abstract]   [Full Text] [Related]  

  • 20. Cycloserine plus ethionamide plus pyrazinamide in the treatment of patients excreting isoniazid-resistant tubercle bacilli following previous chemotherapy.
    Ramakrishnan CV; Parthasarathy R; Sambamoorthy S; Somasundaram PR; Subbammal S
    Indian J Med Res; 1976 Jan; 64(1):76-82. PubMed ID: 818010
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.